CRVS
Corvus Pharmaceuticals, Inc.stockNASDAQ
Market OpenNov 19, 2026 3:07:32 PM EST
10.07USD-1.178%(-0.12)434,093
Pre-marketNov 19, 2026 8:38:30 AM EST
10.15USD-0.393%(-0.04)
CRVS Financials
In Q3 FY 2026 (ended ), Corvus Pharmaceuticals, Inc. (CRVS) reported net income of −$20.34M, operating cash flow of −$12.22M, and assets of $223.88M (filed ).
Loading financial flows…